Seelos Therapeutics (SEEL) Announces Strategic Focus on Mental Health Initiatives and Provides an Update on Current Discussions of Potential Partnerships and Collaborations Apr 29, 2024 08:07AM
Seelos Therapeutics Announces Strategic Focus on Mental Health Initiatives and Provides an Update on Current Discussions of Potential Partnerships and Collaborations Apr 29, 2024 08:00AM
Seelos Therapeutics (SEEL) Retains Canaccord Genuity in Connection with Review of Potential Partnerships and Collaborations Oct 17, 2023 08:02AM
Seelos Therapeutics Retains Canaccord Genuity in Connection with Review of Potential Partnerships and Collaborations Oct 17, 2023 08:00AM
Seelos Therapeutics to Participate in Canaccord Genuity's New Paradigms and Treatment Approaches in Mental Health Conference February 3-4 Feb 1, 2021 08:00AM


Jan 24, 2019 08:01AM Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders
Jan 24, 2019 08:01AM Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders